Investor

InClin

Last cheque observed Nov 2026; 1 cheques on record.

Growth equityDeploying now

Series B

Deploying now
100%of best year1cheques in 12 months, 1 on record
Since the last cheque4days00hrs00min00sec
Median round$30MRounds led1 of 1
Pitch InClin

InClin highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series B: 100% of its rounds

  3. 03

    Led 1 rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2026

    1 round

  2. Nov

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies InClin put money into.

Quick answers about InClin

What does InClin invest in?

InClin invests most often at Series B (100% of the rounds on record).

How active is InClin?

1 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Nov 2026.

What has InClin invested in recently?

Its most recent investments on record: Thryv Therapeutics (Series B, Nov 2026).

How big are InClin's cheques?

The median round it joins is $30M.

Is InClin investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

What kind of investor is InClin?

InClin is a growth equity firm.

Where does this information on InClin come from?

From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it